Sfoglia per AUTORE
IURLO A
Collezione AOU Novara

  

Items : 21

Patient-reported symptom monitoring and adherence to therapy in patients with newly diagnosed chronic myeloid leukemia. in Cancer / Cancer. 2024 Jan;130(2):287-299. doi: 10.1002/cncr.35021. Epub 2023 Oct 6.

2024
AOU Città della Salute di Torino
AOU Novara

Cella D; Cortes J; Vignetti M; Rosti G; Dinner S; Altman JK; Fava C; Abruzzese E; Giai V; Iurlo A; Luciano L; Tiribelli M; Breccia M; Miggiano MC; Capodanno I; Patriarca A; Bonifacio M; Caocci G; Kota V; Castagnetti F; Efficace F; Yanez B; Cottone F;

Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes. in Annals of hematology / Ann Hematol. 2024 Feb;103(2):437-442. doi: 10.1007/s00277-023-05577-9. Epub 2023 Dec 7.

2024
AOU Novara
AOU Città della Salute di Torino

Bellini M; Finazzi MC; Rambaldi A; Tognoni G; Cattaneo D; Vianelli N; Scaffidi L; Bucelli C; Lunghi F; Ramundo F; Betti S; Gesullo F; Guglielmelli P; Calabresi L; Loscocco GG; Cacciola E; Cascavilla N; Mora B; Rumi E; Patriarca A; Siragusa S; Rapezzi D; Musolino C; Caramella M; Pane F; Ricco A; Carli G; Palandri F; Benevolo G; et alii...

Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML. in Cancer / Cancer. 2023 Sep 1;129(17):2637-2644. doi: 10.1002/cncr.34923. Epub 2023 Jun 24.

2023
AO Cuneo
AOU Novara

Pizzuti M; Crugnola M; Malato A; Fava C; Bocchia M; Vincelli I; Luzi D; Rapezzi D; Abruzzese E; Stagno F; Murgano P; Sancetta R; Leporace AP; Scortechini AR; Crisà E; Binotto G; Maggi A; Loglisci G; Mulas O; Bonifacio M; Sorà F; Annunziata M; Russo S; Crescenzi SL; Attolico I; Bucelli C; Cavazzini F; Miggiano MC; Capodanno I; et alii...

Breakthrough infections in MPN-COVID vaccinated patients. in Blood cancer journal / Blood Cancer J. 2022 Nov 15;12(11):154. doi: 10.1038/s41408-022-00749-8.

2022
AOU Novara
AOU Città della Salute di Torino
AO Alessandria

Vannucchi AM; Rambaldi A; Benajiba L; Carbonell S; Kulikowska de Na??cz A; Cattaneo D; Bucelli C; Betti S; Curto-Garcia N; Cavalca F; Borsani O; Guenova M; Navas Elorza B; Angona A; Cichocka E; Lopez Abadia E; Carli G; Xicoy Cirici B; Kusec R; Sagues Serrano M; Garcia-Gutierrez V; Sanchez AM; Hernandez-Boluda JC; Griesshammer M; Kiladjian JJ; Bolaños Calderón E; Heidel FH; Magro Mazo E; Quiroz Cervantes K; et alii...

Second versus first wave of COVID-19 in patients with MPN. in Leukemia / Leukemia. 2022 Mar;36(3):897-900. doi: 10.1038/s41375-022-01507-2. Epub 2022 Jan 21.

2022
AOU Città della Salute di Torino
AOU Novara
AO Alessandria

Quiroz Cervantes K; Benevolo G; Vannucchi AM; Carobbio A; Ghirardi A; Carioli G; Sobas MA; Elli EM; Rumi E; De Stefano V; Curto-Garcia N; Benajiba L; Bellini M; Rambaldi A; Cavalca F; Borsani O; Betti S; Masternak Kulikowska de Na??cz A; Bucelli C; Cichocka E; Cattaneo D; Koschmieder S; Lopez Abadia E; Angona A; Xicoy Cirici B; Navas Elorza B; Kusec R; Sagues Serrano M; Osorio S; et alii...

COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report. in British journal of haematology / Br J Haematol. 2022 Feb;196(3):559-565. doi: 10.1111/bjh.17890. Epub 2021 Oct 11.

2022
AO Cuneo
AOU Città della Salute di Torino
AO Ordine Mauriziano
AOU Novara

Saglio G; Breccia M; Abruzzese E; Accurso V; Attolico I; Barulli S; Bergamaschi M; Binotto G; Foà R; Sportoletti P; Stagno F; Tafuri A; Tiribelli M; Rita Scortechini A; Sorà F; Sancetta R; Russo S; Rosti G; Rege-Cambrin G; Pregno P; Rapezzi D; Pizzuti M; Cristina Miggiano M; La Barba G; Latagliata R; Leonetti Crescenzi S; Levato L; Loglisci G; Lucchesi A; et alii...

Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID-19. in American journal of hematology / Am J Hematol. 2022 Dec;97(12):E470-E473. doi: 10.1002/ajh.26732. Epub 2022 Sep 27.

2022
AOU Città della Salute di Torino
AOU Novara
AO Alessandria

Vannucchi AM; Rambaldi A; Curto-Garcia N; Cavalca F; Bellini M; Betti S; Borsani O; de Na??cz AK; Cattaneo D; Bucelli C; Cichocka E; Koschmieder S; Lopez Abadia E; Kusec R; Xicoy Cirici B; Angona A; Navas Elorza B; Sagues Serrano M; Carreno-Tarragona G; Osorio S; Carli G; Hernandez-Boluda JC; Garcia-Gutierrez V; Marin Sanchez A; Magro Mazo E; Griesshammer M; Quiroz Cervantes K; Bolaños Calderón E; Patriarca A; et alii...

Deferasirox in the management of iron overload in patients with myelofibrosis treated with ruxolitinib: The multicentre retrospective RUX-IOL study. in British journal of haematology / Br J Haematol. 2022 Apr;197(2):190-200. doi: 10.1111/bjh.18057. Epub 2022 Feb 8.

2022
AOU Città della Salute di Torino
AOU Novara

Caramella M; Cilloni D; Latagliata R; Palandri F; Abruzzese E; Bonifacio M; Palumbo GA; Gambacorti-Passerini C; Breccia M; Bucelli C; Scaffidi L; Biale L; Cattaneo D; Trawinska MM; Auteri G; Markovic U; Renso R; Crisà E; Porrini R; Caocci G; Pugliese N; Polverelli N; Tiribelli M; Bergamaschi M; Benevolo G; Carmosino I; Bartoletti D; Iurlo A; Di Veroli A; et alii...

Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial. in The Lancet. Haematology / Lancet Haematol. 2021 Mar;8(3):e175-e184. doi: 10.1016/S2352-3026(20)30373-2. Epub 2021 Jan 18.

2021
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Tognoni G; Finazzi MC; Bellini M; Bucelli C; Lunghi F; Vianelli N; Scaffidi L; Betti S; Guglielmelli P; Loscocco GG; Mora B; Cacciola E; Mannarelli C; Patriarca A; Cascavilla N; Rumi E; Siragusa S; Musolino C; Caramella M; Rapezzi D; Ricco A; Carli G; Palandri F; Pane F; Benevolo G; Bonifacio M; Iurlo A; Ciceri F; Ghirardi A; et alii...

Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study. in Cancer medicine / Cancer Med. 2021 Mar;10(5):1726-1737. doi: 10.1002/cam4.3778. Epub 2021 Feb 16.

2021
AOU San Luigi di Orbassano
AOU Novara

Polverelli N; Bernardi S; Farina M; Gandolfi L; Bocchia M; Aprile L; Russo Rossi A; Russo S; Tiribelli M; Romano A; Rege Cambrin G; Corsetti MT; Coppi MR; Sancetta R; Lemoli RM; Rosti G; Castagnetti F; Ferrari ML; Lunghi F; Crugnola M; Lunghi M; D'Adda M; Binotto G; Stagno F; Bonifacio M; Abruzzese E; Iurlo A; Malagola M; Roccaro AM; et alii...

Validation and reference values of the EORTC QLQ-CML24 questionnaire to assess health-related quality of life in patients with chronic myeloid leukemia. in Leukemia & lymphoma / Leuk Lymphoma. 2021 Mar;62(3):669-678. doi: 10.1080/10428194.2020.1838509. Epub 2020 Nov 6.

2021
AOU Novara

Efficace F; Iurlo A; Patriarca A; Stagno F; Bee PC; Ector G; Capodanno I; Elena C; Bonifacio M; Blijlevens NMA; Caocci G; Wan C; Abruzzese E; Breccia M; Cottone F; Okumura I; Oerlemans S; Cascavilla N; Albano F; Kota V; Sztankay M; Miggiano MC; Saussele S; Di Renzo N; Sorà F; Castagnetti F; Baccarani M; Vignetti M; Rosti G; et alii...

Long-term follow-up of recovered MPN patients with COVID-19. in Blood cancer journal / Blood Cancer J. 2021 Jun 16;11(6):115. doi: 10.1038/s41408-021-00509-0.

2021
AOU Città della Salute di Torino
AOU Novara

Salmoiraghi S; Rambaldi A; Bellosillo B; Guglielmelli P; Koschmieder S; Borsani O; Betti S; Benajiba L; Garrote M; Cavalca F; Curto-Garcia N; Bellini M; Daffini R; Cuevas B; Cattaneo D; Sobas MA; Xicoy Cirici B; Ruggeri M; Angona A; Hernandez-Boluda JC; Lopez Abadia E; De Stefano V; Bonifacio M; Magro Mazo E; Lunghi F; Garcia-Gutierrez V; Navas Elorza B; Benevolo G; Patriarca A; et alii...

Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19. in Blood cancer journal / Blood Cancer J. 2021 Feb 4;11(2):21. doi: 10.1038/s41408-021-00417-3.

2021
AOU Città della Salute di Torino
AOU Novara

Rambaldi A; Vannucchi AM; Betti S; Harrison C; Curto-Garcia N; Cavalca F; Bellini M; Benajiba L; Bellosillo B; Garrote M; Cattaneo D; Daffini R; Guglielmelli P; Cirici BX; Abadia EL; Carli G; Cuevas B; Hernandez-Boluda JC; Koschmieder S; Angona A; Mazo EM; Lunghi F; Patriarca A; Elorza BN; Serrano MS; Carreno-Tarragona G; Sobas MA; Bonifacio M; Cervantes KSQ; et alii...

High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib. in Leukemia / Leukemia. 2021 Feb;35(2):485-493. doi: 10.1038/s41375-020-01107-y. Epub 2021 Jan 7.

2021
AOU Città della Salute di Torino
AOU Novara

Betti S; Harrison C; De Stefano V; Bellini M; Bellosillo B; Benajiba L; Curto-Garcia N; Daffini R; Cavalca F; Cattaneo D; Garrote M; Cirici BX; Guglielmelli P; Abadia EL; Hernandez-Boluda JC; Cuevas B; Ruggeri M; Koschmieder S; Mazo EM; Angona A; Elorza BN; Patriarca A; Carreno-Tarragona G; Sobas MA; Lunghi F; Papadopoulos P; Bonifacio M; Cervantes KSQ; Serrano MS; et alii...

Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study. in Blood / Blood. 2020 Jan 30;135(5):381-386. doi: 10.1182/blood.2019002614.

2020
ASL Asti
AO Cuneo
AOU Città della Salute di Torino
ASL Vercelli
AOU Novara

Di Veroli A; Barbui T; Vannucchi AM; Rambaldi A; Griesshammer M; Alvarez-Larran A; Marchetti M; Isfort S; Recasens V; McMullin MF; Tieghi A; Carli G; Cacciola R; Benevolo G; Fox ML; Beggiato E; Angona A; Lunghi F; Wille K; Perez-Encinas M; Gomez M; Erez D; Rapezzi D; Elli EM; Palova M; Casetti IC; Stephenson C; Guglielmelli P; Scaffidi L; et alii...

Health-related quality of life of newly diagnosed chronic myeloid leukemia patients treated with first-line dasatinib versus imatinib therapy. in Leukemia / Leukemia. 2020 Feb;34(2):488-498. doi: 10.1038/s41375-019-0563-0. Epub 2019 Sep 2.

2020
AOU Città della Salute di Torino
AOU Novara

Rosti G; Binotto G; Vignetti M; Bergamaschi M; Fozza C; Cascavilla N; Saussele S; Pregno P; Gozzini A; Patriarca A; Capodanno I; Martino B; Tiribelli M; Crugnola M; Caocci G; Castagnetti F; Abruzzese E; Cottone F; Bonifacio M; Breccia M; Iurlo A; Efficace F; Stagno F;

Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation. in Cancer medicine / Cancer Med. 2019 May;8(5):2041-2055. doi: 10.1002/cam4.2087. Epub 2019 Apr 4.

2019
AOU Novara

Bernardi S; Malagola M; Zanaglio C; Polverelli N; Dereli Eke E; D'Adda M; Farina M; Bucelli C; Scaffidi L; Toffoletti E; Deambrogi C; Stagno F; Bergamaschi M; Franceschini L; Abruzzese E; Divona MD; Gobbi M; Di Raimondo F; Gaidano G; Tiribelli M; Bonifacio M; Cattaneo C; Iurlo A; Russo D;

Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP. in Blood advances / Blood Adv. 2019 Dec 23;3(24):4280-4290. doi: 10.1182/bloodadvances.2019000865.

2019
AOU Città della Salute di Torino
AO Cuneo
AO Alessandria
AOU Novara

Soverini S; Vigneri P; Rosti G; Bonifacio M; Breccia M; Castagnetti F; Saglio G; Pane F; Russo D; Trabacchi E; Spadano R; Stagno F; Tiribelli M; Tomassetti S; Sancetta R; Sica S; Salvucci M; Rupoli S; Rege-Cambrin G; Rapezzi D; Pregno P; Miggiano MC; Montefusco E; Musolino C; Palmieri F; Malagola M; Melpignano A; Martino B; Marasca R; et alii...

High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists. in Leukemia / Leukemia. 2016 Oct;30(10):2032-2038. doi: 10.1038/leu.2016.85. Epub 2016 Apr 26.

2016
AO Cuneo
AOU Novara

Barbui T; Vannucchi AM; Sant'Antonio E; Griesshammer M; Carobbio A; Musolino C; Rapezzi D; Forcina A; Pungolino E; Specchia G; Hernandez-Boluda JC; Tieghi A; Ellis MH; Cacciola R; Palova M; Cattaneo D; Nichele I; Betti S; Rossi E; Gaidano G; Zetterberg E; Vianelli N; Finazzi G; Finazzi MC; Elli E; Randi ML; Alvarez-Larrán A; Iurlo A; Ruggeri M; et alii...

Adherence and future discontinuation of tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia. A patient-based survey on 1133 patients. in Leukemia research / Leuk Res. 2015 Oct;39(10):1055-9. doi: 10.1016/j.leukres.2015.07.004. Epub 2015 Jul 14.

2015
AOU Novara

Breccia M; Efficace F; Sica S; Abruzzese E; Cedrone M; Turri D; Gobbi M; Carella AM; Gozzini A; Usala E; Cavazzini F; Danise P; Tiribelli M; Binotto G; Pregno P; Bocchia M; Gaidano G; Crugnola M; Bonifacio M; Avanzini P; Celesti F; Guella A; Martino B; Annunziata M; Luciano L; Stagno F; Vallisa D; Pungolino E; Iurlo A; et alii...

Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: an observational, hypothesis-generating study. in Drug design, development and therapy / Drug Des Devel Ther. 2015 May 18;9:2687-94. doi: 10.2147/DDDT.S79576. eCollection 2015.

2015
AOU Novara

Cascavilla N; De Stefano V; Pane F; Pancrazzi A; Iurlo A; Gobbi M; Palandri F; Specchia G; Liberati AM; D'Adda M; Gaidano G; Fjerza R; Achenbach H; Smith J; Wilde P; Vannucchi AM;